Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification
- PMID: 25398793
Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification
Abstract
This article reviews epidemiology, risk factors, pathogenesis and diagnosis of melanoma. Data on melanoma from the majority of countries show a rapid increase of the incidence of this cancer, with a slowing of the rate of incidence in the period 1990-2000. Males are approximately 1.5-times more likely to develop melanoma than females, while according to other studies, the different prevalence in both sexes must be analyzed in relation with age: the incidence rate of melanoma is grater in women than men until they reach the age of 40 years, however, by 75 years of age, the incidence is almost 3-times as high in men versus women. The most important and potentially modifiable environmental risk factor for developing malignant melanoma is the exposure to ultraviolet (UV) rays because of their genotoxic effect. Artificial UV exposure may play a role in the development of melanoma. The most important host risk factors are the number of melanocytic nevi, familiar history and genetic susceptibility. A patient with a personal history of melanoma must be considered at greater risk for subsequent melanoma. Indeed approximately 1-8% of patients with prior history of melanoma will develop multiple primary melanomas. We herein review the dermatological diagnosis and classification of melanoma.
Keywords: Melanoma; classification; dermoscopy; diagnosis; epidemiology; pathogenesis; reflect confocal microscopy; review; risk factors.
Copyright © 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Similar articles
-
Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.Acta Oncol. 2010 Jun;49(5):665-72. doi: 10.3109/02841861003702528. Acta Oncol. 2010. PMID: 20491525
-
[Malignant melanoma of the skin. Epidemiology, risk factors, clinical diagnosis].Cas Lek Cesk. 1996 Jul 26;135(13):405-8. Cas Lek Cesk. 1996. PMID: 8925536 Czech.
-
Reviews on sun exposure and artificial light and melanoma.Prog Biophys Mol Biol. 2011 Dec;107(3):362-6. doi: 10.1016/j.pbiomolbio.2011.09.011. Epub 2011 Sep 19. Prog Biophys Mol Biol. 2011. PMID: 21958910 Review.
-
Epidemiology and etiology of malignant melanoma.Biomed Pharmacother. 1986;40(3):91-9. Biomed Pharmacother. 1986. PMID: 3527290 Review.
-
Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.Arch Dermatol. 2005 Aug;141(8):998-1006. doi: 10.1001/archderm.141.8.998. Arch Dermatol. 2005. PMID: 16103329
Cited by
-
Gender Differences and Outcomes in Melanoma Patients.Oncol Ther. 2020 Jun;8(1):103-114. doi: 10.1007/s40487-020-00109-1. Epub 2020 Feb 4. Oncol Ther. 2020. PMID: 32700073 Free PMC article.
-
Osteoporosis in Skin Diseases.Int J Mol Sci. 2020 Jul 3;21(13):4749. doi: 10.3390/ijms21134749. Int J Mol Sci. 2020. PMID: 32635380 Free PMC article. Review.
-
Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells.In Vivo. 2024 Jul-Aug;38(4):1579-1593. doi: 10.21873/invivo.13608. In Vivo. 2024. PMID: 38936891 Free PMC article.
-
Additive Interactions between Betulinic Acid and Two Taxanes in In Vitro Tests against Four Human Malignant Melanoma Cell Lines.Int J Mol Sci. 2022 Aug 25;23(17):9641. doi: 10.3390/ijms23179641. Int J Mol Sci. 2022. PMID: 36077036 Free PMC article.
-
The evaluation of tumor microenvironment infiltration and the identification of angiogenesis-related subgroups in skin cutaneous melanoma.J Cancer Res Clin Oncol. 2023 Aug;149(10):7259-7273. doi: 10.1007/s00432-023-04680-8. Epub 2023 Mar 13. J Cancer Res Clin Oncol. 2023. PMID: 36912943
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical